Stock Rich List
#6678 on the rich list of 14,644 insiders

Julia G. Butchko

Chief Development Officer at Immunovant. Based in New York, New York.

$14.3M
in disclosed stock, −$287K (−1.96%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
6678th of 14,644
Companies held
1
Largest holding
IMVT, 100.0% of total
Latest SEC filing
Aug 21, 2024

What the $14.3M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Immunovant IMVT
Common Stock
Directly440,959$32.52$14.3M100.0%Form 4, Aug 21, 2024

Share counts are the amounts Julia G. Butchko reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
6675Robert J. Alpern
Director, AbbVie. North Chicago, IL
$14.3M−$113K (−0.78%)
6676Rodger Levenson
President & CEO, WSFS Financial. Wilmington, DE
$14.3M−$226K (−1.55%)
6677Gavin Hattersley
President & CEO, Molson Coors Beverage. Hunt Valley, MD
$14.3M−$397K (−2.69%)
6678Julia G. Butchko
Chief Development Officer, Immunovant. New York, NY
$14.3M−$287K (−1.96%)
6679Lorie Tekorius
CEO and President, The Greenbrier Companies. Lake Oswego, OR
$14.3M−$486K (−3.28%)
6680Sherry S. Bahrambeygui
Director, PriceSmart. San Diego, CA
$14.3M−$48K (−0.33%)
6681David. R. Brennan
Director, Insmed. Bridgewater, NJ
$14.3M+$2.4M (+20.58%)

Other Immunovant insiders

All IMVT insiders

Questions

How much stock does Julia G. Butchko own?

Julia G. Butchko holds $14,339,987 in listed stock based on SEC filings and current prices, mostly Immunovant (IMVT). That ranks 6678th on the Stock Rich List.

Is this Julia G. Butchko's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.